Preview Mode Links will not work in preview mode

Karger - Fast Facts Oncology

Sep 1, 2023

This is the third episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management.

In this episode, Dr. DiNardo discusses the missing pieces of MDS management, starting with the latest approvals in MDS treatment and how eligibility...


Sep 1, 2023

This is the second episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management.

In this episode, Dr. Griffiths discusses what makes Real World Evidence and how it is obtained or archived, the risk stratification of MDS and what...


Sep 1, 2023

This is the first episode in our series on myelodysplastic syndromes which aims to update clinicians on the latest developments in their diagnosis and management.

In this episode, Dr. DeFilipp outlines the current and upcoming treatments for myelodysplastic syndromes. He discusses doublet and triplet combinations that...


Jun 26, 2023

This is the third episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management.

In this episode, Melinda Bachini discusses the use of biomarker testing in cholangiocarcinoma. From the perspective of a patient advocate, she explains how to relay...


Jun 26, 2023

This is the second episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management.

In this episode, Dr. Marina Baretti discusses the safety of fibroblast growth factor receptor (FGFR) inhibitors, drawing from her clinical experience. She details...